The PI3K/Akt/mTOR pathway is involved in growth, survival and drug resistance in MM plasma cells. This signaling pathway is also involved in managing establishment and activity of osteoblasts and osteoclasts. This evidence concerns the gene MTOR and Miyoshi myopathy.